These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 945238)

  • 1. Defective leukotaxis in patients with lepromatous leprosy.
    Ward PA; Goralnick S; Bullock WE
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):243-9. PubMed ID: 945238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective leukotaxis in patients with lepromatous leprosy.
    Ward PA; Goralnick S; Bullock WE
    J Lab Clin Med; 1976 Jun; 87(6):1025-32. PubMed ID: 778311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory dysfunction in leukotaxis.
    Ward PA; Johnson KJ; Kreutzer DL
    Am J Pathol; 1977 Sep; 88(3):701-10. PubMed ID: 142429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phagocytosis in leprosy. III. Defective adhesive and endocytic abilities of circulating leukocytes in lepromatous leprosy.
    Rojas-Espinosa O; Aponte-Vázquez J; González Cruz O; Estrada-Parra S; Ortiz Y
    Int J Lepr Other Mycobact Dis; 1980 Jun; 48(2):159-66. PubMed ID: 7190552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunobiology of leprosy.
    Kaplan G; Cohn ZA
    Int Rev Exp Pathol; 1986; 28():45-78. PubMed ID: 3516911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between the C5 peptides chemotactic for leukocytes and tumor cells.
    Romualdez AG; Ward PA; Torikata T
    J Immunol; 1976 Nov; 117(5 Pt.2):1762-6. PubMed ID: 62790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of macrophages in defective cell mediated immunity in lepromatous leprosy. II. Macrophage and lymphocyte interaction.
    Birdi TJ; Salgame PR; Mahadevan PR; Antia NH
    Int J Lepr Other Mycobact Dis; 1980 Jun; 48(2):178-82. PubMed ID: 6967461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of levamisole on clinical outcome and DNCB conversion in leprosy patients. A long term study.
    Yagnik CS; Jogaikar DG; Mehta JM
    Lepr India; 1983 Jan; 55(1):68-70. PubMed ID: 6680021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of the immune state in leprosy.
    Mehra NK; Dasgupta A; Vaidya MC
    Lepr India; 1976 Jul; 48(3):231-7. PubMed ID: 15165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transformation from lepromatous to borderline leprosy under clofazimine therapy.
    Mahapatra SB; Ramu G
    Lepr India; 1976 Apr; 48(2):172-6. PubMed ID: 1022964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective monocyte chemotaxis in active lepromatous leprosy.
    Schuller-Levis G; Harris D; Cutler E; Meeker HC; Haubenstock H; Levis WR
    Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):267-72. PubMed ID: 3298473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etiological factors in delayed-type hypersensitivity reactions in leprosy.
    Klenerman P
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):702-12. PubMed ID: 3123582
    [No Abstract]   [Full Text] [Related]  

  • 13. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dapsone resistant leprosy, the western Kenya experience.
    Orege PA; Owili DM
    Trop Geogr Med; 1985 Jun; 37(2):139-42. PubMed ID: 4035777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunodeficiency in leprosy.
    Lim SD; Kiszkiss DF; Choi YS; Gajl-Peczalska K; Good RA
    Birth Defects Orig Artic Ser; 1975; 11(1):244-9. PubMed ID: 1096981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
    Reitan LJ; Closs O; Belehu A
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of macrophages in defective cell mediated immunity in lepromatous leprosy. I. Factor(s) from macrophages affecting protein synthesis and lymphocyte transformation.
    Salgame PR; Birdi TJ; Mahadevan PR; Antia NH
    Int J Lepr Other Mycobact Dis; 1980 Jun; 48(2):172-7. PubMed ID: 7190553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNCB contact sensitization in leprosy: its comparison with other CMI tests.
    Jayasingh K; Bhatia VN
    Indian J Lepr; 1984; 56(2):207-11. PubMed ID: 6548491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic aspects of leprosy as related to leucocytic isoantibodies and platelet aggregating factors.
    Saha K; Dutta RN; Mittal MM
    Int J Lepr Other Mycobact Dis; 1975; 43(3):239-48. PubMed ID: 1082859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective regulation of chemotaxis in cirrhosis.
    Maderazo EC; Ward PA; Quintiliani R
    J Lab Clin Med; 1975 Apr; 85(4):621-30. PubMed ID: 1120929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.